logo

SMMT

Summit Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
3.61 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Trend Analysis of SMMT
  • Based on a composite score of 3.61/10, we rate SMMT as a Netural. Our analysis breaks down into 2.69/10 for Fundamentals, 4.12/10 for Technicals, and 3.83/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is SMMT undervalued or overvalued?
Technical Analysis of SMMT?
Is money flowing into or out of SMMT?